AlphaSimPlex Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-13,669
Closed -$588K 183
2021
Q3
$588K Sell
13,669
-5,980
-30% -$265K 0.49% 71
2021
Q2
$769K Hold
19,649
0.38% 116
2021
Q1
$712K Hold
19,649
0.3% 165
2020
Q4
$723K Sell
19,649
-4,493
-19% -$165K 0.25% 194
2020
Q3
$841K Buy
24,142
+3,660
+18% +$128K 0.38% 109
2020
Q2
$635K Buy
+20,482
New +$696K 0.48% 75
2019
Q3
Sell
-40,354
Closed -$1.66M 221
2019
Q2
$1.66M Sell
40,354
-2,023
-5% -$80.3K 0.52% 38
2019
Q1
$1.71M Buy
+42,377
New +$1.7M 0.58% 45

Other funds holding PFE

AlphaSimPlex Group's PFE Position: Q4 2021 in Review

AlphaSimPlex Group sold out of Pfizer (PFE) in Q4 2021, closing a stake of 13,669 shares — an estimated $588K sold.

AlphaSimPlex Group first reported a position in PFE in Q1 2019 and held it in 8 quarters. The position peaked at $1.71M in Q1 2019. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

  • AlphaSimPlex Group reported no remaining Pfizer position as of Q4 2021 after selling out during the quarter.
  • AlphaSimPlex Group sold 13,669 Pfizer shares in Q4 2021, an estimated $588K.
  • AlphaSimPlex Group first reported a position in Pfizer in Q1 2019 and held it in 8 quarters.
  • AlphaSimPlex Group's Pfizer position peaked at $1.71M in Q1 2019.
  • 3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on AlphaSimPlex Group's 13F filing for Q4 2021, filed 10 Feb 2022.